Recommendations & Conclusions
4 items
1
Conclusion
Eleventh Report - The rollout of the CO…
Not Addressed
On the basis of a report by the Comptroller and Auditor General, we took evidence from the Department of Health and Social Care (the Department), the Department for Business, Energy and Industrial Strategy (BEIS), NHS England and NHS Improvement (NHS England), the UK Health and Security Agency (UKHSA) and the …
Read more
On the basis of a report by the Comptroller and Auditor General, we took evidence from the Department of Health and Social Care (the Department), the Department for Business, Energy and Industrial Strategy (BEIS), NHS England and NHS Improvement (NHS England), the UK Health and Security Agency (UKHSA) and the Vaccine Taskforce (the Taskforce), on the rollout of the COVID-19 vaccination programme in England.1 The evidence session took place on the 28 March and our report is based on both the session and other evidence supplied to us at the time.
Show less
Government response AI summary
The government response merely repeats the committee's introductory statement about the report's origins and scope, without providing any substantive comment or action.
Read full response →
HM Treasury
13
Conclusion
Eleventh Report - The rollout of the CO…
Not Addressed
However, effective targeting is now essential because those who are not fully vaccinated are concentrated in particular social groups. According to NHS England, many unvaccinated people are young city-dwellers, with just five cities accounting for a quarter of the total number of unvaccinated people.30 Data confirm that young people are …
Read more
However, effective targeting is now essential because those who are not fully vaccinated are concentrated in particular social groups. According to NHS England, many unvaccinated people are young city-dwellers, with just five cities accounting for a quarter of the total number of unvaccinated people.30 Data confirm that young people are indeed less likely to be vaccinated, including school children. Overall uptake of COVID vaccination had reached 90% of adults by the end of May 2022 (based on 2 doses). But by the same point, only 55% of young people aged 16 and 17 had received 2 doses, and only 38% of 12- to 15-year-olds.31 Even allowing for the later starting point of these campaigns, this is a significant difference.
Show less
Government response AI summary
The government disagreed with the committee's recommendation to reduce the overall number of unvaccinated adults to 2.5 million and achieve an 80% uptake for first boosters among adults within four months. They stated they continue to focus on reaching out to the unvaccinated and not …
Read full response →
HM Treasury
16
Conclusion
Eleventh Report - The rollout of the CO…
Not Addressed
Additionally, Mencap raised concerns with us about specific difficulties in identifying and prioritising people with severe and profound learning disabilities.38 It said there was a need for more accessible communications for this group and to tackle needle phobia, which had not always been consistently or effectively addressed to date.39
Read more
Additionally, Mencap raised concerns with us about specific difficulties in identifying and prioritising people with severe and profound learning disabilities.38 It said there was a need for more accessible communications for this group and to tackle needle phobia, which had not always been consistently or effectively addressed to date.39
Show less
Government response AI summary
The government agrees with the Committee’s recommendation that NHS England and UKHSA should urgently evaluate which approaches are most effective for increasing vaccine uptake, communicate again with local areas about what works, and provide support to them to deploy the most effective approaches, but focuses …
Read full response →
HM Treasury
32
Conclusion
Eleventh Report - The rollout of the CO…
Finally, we note that in setting up the vaccine programme the Department provided indemnities to vaccine manufacturers, which gave cover for future claims against producers for any adverse effects of their vaccines. These indemnities may add to the costs of the programme in the long term.80 We heard from one …
Read more
Finally, we note that in setting up the vaccine programme the Department provided indemnities to vaccine manufacturers, which gave cover for future claims against producers for any adverse effects of their vaccines. These indemnities may add to the costs of the programme in the long term.80 We heard from one individual whose relative had suffered side-effects as a result of vaccination. Their evidence underlined the importance of having clear, prompt and adequate compensation. arrangements for people in need. The Department told us it had a substantial number of contingent liabilities related to 73 Q66; C&AG’s Report, paras 15 and 2.19 74 C&AG’s Report, para 1.9, Figure 1 75 Qq 71–73 76 Qq 1–4; RCP0008 Note dated March 2022 from the Company Chemists’ Association, page 6, and RCP0010 Note dated March 2022 from The Association of Directors of Public Health page 7–8 77 C&AG’s Report, paras 2, 1.16, Figure 1 78 RCP0010 Note dated March 2022 from The Association of Directors of Public Health, page 7 79 Qq 74–75 80 C&AG’s Report, para 1.8 18 The rollout of the COVID-19 vaccine programme in England these indemnities and that it was seeking to reduce their value.81 The Committee will potentially want to know more about the Department’s arrangements and plans in this regard in due course.82 81 Qq 25–26 82 Q 27 The rollout of the COVID-19 vaccine programme in England 19
Show less
HM Treasury